TELO Telomir Pharmaceuticals, Inc.
$1.01▲ +1.16%
Healthcare
Other
Volume 5.9K
Avg Volume (10D) 58.3K
Key Metrics & Fundamentals
Market Cap
$74.36M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.89 - 1.58
% vs 50 MA
-12.30%
% vs 200 MA
-18.83%
RSI-14
34.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.60
Free Cash Flow
-$1.01M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.72M
COGS
–
Operating Exp
$1.76M
Operating Income
-$1.76M
EBIT
-$1.76M
Pretax Income
-$1.72M
Net Income
-$1.72M
EPS (Diluted)
-0.79
Price & Volume History
Loading chart…
Recent News
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
GlobeNewswire · Oct 6, 2026 8:00 AM ET
Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
GlobeNewswire · Sep 17, 2026 8:30 AM ET
Telomir Announces Research with The Ohio State University Demonstrating In-Vitro Anti-Cancer Activity in Human and Canine Osteosarcoma Models
GlobeNewswire · Sep 14, 2026 8:00 AM ET
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
GlobeNewswire · Aug 10, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TELO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.